- Clone
- W23119G (See other available formats)
- Regulatory Status
- RUO
- Other Names
- TMIGD2, Transmembrane And Immunoglobulin Domain Containing 2, IGPR-1, CD28H
- Isotype
- Rat IgG2a, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 648725 | 100 µg | 272€ | ||||
| 648726 | 1 mg | 680€ | ||||
CD28 homolog (CD28H), also referred to as TMIGD2 (Transmembrane and Immunoglobulin Domain Containing 2) and IGPR-1 (Immunoglobulin-containing and Proline-rich Receptor-1), is a member of the immunoglobulin superfamily. It is predominantly expressed in epithelial and endothelial cells. The CD28H structure consists of an extracellular domain resembling an immunoglobulin V-like (IgV-like) domain, which contains two potential glycosylation sites. It also features a transmembrane segment and a cytoplasmic tail with a tyrosine residue. CD28H was previously recognized both as a co-stimulatory receptor and as an adhesion molecule. HHLA2 (B7-H7) is the known ligand for CD28H. Connection of the CD28H and HHLA2 primarily co-stimulates human T cell growth through an Akt-dependent signaling cascade which mediate tumor resistance against NK cells and promotes cytokine production. CD28H is associated with immune dysregulation and angiogenesis. In autoimmune diseases, abnormal CD28H signaling can cause inappropriate T cell activation, resulting in tissue damage. Additionally, CD28H expression can promote the abnormal self-renewal and differentiation of acute myeloid leukemia cells via downstream signaling pathways like ERK1/2-p90RSK-CREB signaling. Targeting CD28 signaling with anti-CD28 mAb attenuates self-renewal of leukemia stem cells, providing promising therapeutic value.
Product DetailsProduct Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant Human CD28H (TMIGD2)
- Formulation
- 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
- Endotoxin Level
- Less than 0.01 EU/μg of the protein (< 0.001 ng/μg of the protein) as determined by the LAL test
- Preparation
- The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
- Application
-
Block - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by blocking the binding of 400 ng/mL Biotinylated Recombinant Human CD28H-Fc Chimera to 1 μg/mL immobilized Recombinant Human B7-H7. ND50 range: 0.08 – 0.48 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.
Antigen Details
- Structure
- Dimer
- Distribution
-
NK cell, T cell, epithelial and endothelial cells
- Function
- Regulates lymphocyte responses, boosts T-cell proliferation, and plays a crucial role in cell migration and the formation of new blood vessels.
- Interaction
- B7-H7/HHLA2
- Ligand/Receptor
- B7 family
- Cell Type
- Epithelial cells, NK cells, T cells
- Biology Area
- Angiogenesis, Cancer Biomarkers, Cell Biology, Immuno-Oncology, Immunology
- Antigen References
-
- Burke, Kelly P et al. 2024. Immunity. 57(2): 223-244.
- Zhu Yuwen, et al. 2013. Nat Commun. 4:2043.
- Kula Agnieszka, et al. 2024. Cells. 13:794
- Wang Hao, et al. 2024. Nature communications. 15.11.
- Janakiram Murali, et al. 2017. Immunol Rev. 276:26-39.
- Nagai Shigenori and Miyuki Azuma. 2019. Advances in experimental medicine and biology. 1189: 25-51.
- Zhong C, et al. 2020. Clinical and experimental immunology. 200:12-21
- Tian Yu, et al. 2018. Oncoimmunology. 8:e1538440
- Ying Honggang, et al. 2022. EBioMedicine. 79:103987.
- Amraei Razie, et al. 2020. J Biol Chem. 295:16691-1669.
- Gene ID
- 126259 View all products for this Gene ID
- UniProt
- View information about CD28H on UniProt.org
Related FAQs
- Do you guarantee that your antibodies are totally pathogen free?
-
BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.
- Does BioLegend test each Ultra-LEAF™ antibody by functional assay?
-
No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.
- Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?
-
No, BioLegend does not test for pathogens in-house unless otherwise indicated. However, we can recommend an outside vendor to perform this testing as needed.
- Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?
-
We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.
Other Formats
View All CD28H (TMIGD2) Reagents Request Custom Conjugation| Description | Clone | Applications |
|---|---|---|
| Ultra-LEAF™ Purified anti-human CD28H (TMIGD2) | W23119G | Block |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Ultra-LEAF™ Purified anti-human CD28H (TMIGD2)
Biotinylated Recombinant Human CD28H-Fc Chimera (carrier-fre...
Login / Register 


Follow Us